Origin Merchant Partners (“Origin”) is pleased to announce that it acted as exclusive financial advisor to Burke & Company Ltd.,(“Burke & Co”) and Orion Audit (“Orion”) on their sale to Navacord.
Burke & Co and Orion: Founded in 1991 in Toronto, Ontario, Burke & Co is a distinguished consulting and claims auditing firm, with a unique value proposition that brings together their consulting arm and their expertise in audit, claims control and fraud analytics. Specializing in providing personalized, cost-effective consulting and claims audit services focused on optimizing benefit and pension plans for a diverse clientele, including some of Canada’s leading employers, and with a very strong footprint in healthcare. Burke & Co’s client base spans various industries and organizational sizes, maintaining strong industry relationships with major retirement providers and insurance companies through professional and consistent practices.
Navacord: Founded in 2014 and headquartered in Toronto, Ontario, Navacord is one of Canada’s top three commercial insurance brokerages. With $3 billion in premiums, Navacord stands as a leader in group insurance and risk management solutions. From commercial and personal insurance to surety, employee benefits and retirement consulting, Navacord leverages national strength and resources with the local touch service of industry-specialized Navacord Broker Partners to deliver the trusted advice, expertise and custom insurance solutions clients need to face the future with confidence.
The Navacord partnership with Burke & Co and Orion complements Navacord’s ongoing build within the benefits, financial services, and wealth planning sector, bolstered by specialized expertise in claims and fraud analytics.
Origin Senior Leads: Peter Farrell, Cathy Steiner
Origin Merchant Partners (“Origin”) is pleased to announce that it served as the exclusive financial advisor to Centricity Research (“Centricity” or the “Company”) on a sale of a majority stake by its shareholders, Persistence Capital Partners and management, to Trinity Hunt Partners (“THP”).
Centricity is the operating company formed through the integration of three research network organizations (LMC Manna Research, iACT Health, and Aventiv Research). The Company is a leading clinical research services provider to pharmaceutical sponsors and CRO’s, and specializes in conducting Phase I-IV clinical trials across more than 40 therapeutic areas, from its 35 locations spanning the US and Canada. Centricity’s centralized processes, expansive patient recruitment capabilities, integrated technology, and dedicated team of clinical research professionals have successfully led to over 2,500 studies conducted and more than 100 FDA and Health Canada drug approvals.
THP is a growth-oriented private equity firm headquartered in Dallas, Texas with over $1.7 billion of assets under management, focused on building leading business, healthcare, and consumer services companies. The firm has invested in more than 28 platform companies over the past 17 years.
Origin Senior Leads: Lindsay Adam Weiss, Cathy Steiner, Christopher Solda.
Origin Merchant Partners is pleased to announce that Back in Motion Rehab (“BIM”), previously a portfolio company of Ironbridge Equity Partners (“Ironbridge”), has been acquired by Yorkville Asset Management (“Yorkville”) on behalf of its Yorkville Health Care Fund and private placement investments, Yorkville Private Equity LP and Yorkville Private Lending LP. Origin Merchant Partners acted as exclusive financial advisor to Back in Motion with respect to this transaction.
BIM is an industry leader for physiotherapy, massage, active rehabilitation, occupational therapy, psychological services, and multidisciplinary treatment programs. For 30 years, BIM has delivered accessible and evidence-based healthcare services for a range of customers, including individuals, WorkSafeBC, insurance companies, government, and employers. BIM has grown its footprint to 10 clinics across the Metro Vancouver area.
Ironbridge is a Toronto-based private equity firm with more than $750 million of assets under management, focused exclusively on investing in Canadian, lower middle-market businesses in the manufacturing, distribution, consumer products and services, and business products and services spaces.
Yorkville is a boutique investment management firm based in Toronto that caters to both private clients and institutional investors. Yorkville provides clients with well-diversified portfolios that can include its highly ranked fixed income strategy, various equity mandates, as well as a number of alternative investment solutions such as Real Estate, Private Equity, Pre-IPO Equity, and Private Debt.
Origin Senior Leads: Cathy Steiner, Jim Osler.
Origin Merchant Partners is pleased to announce that Think Research Corporation (“Think”) has closed an initial advance of $10 million from Beedie Investments Ltd (“Beedie”) under a convertible loan facility of up to $25 million. Origin Merchant Partners was the exclusive financial advisor to Think with respect to this transaction.
Think (TSXV: THNK) (OTCQB: THKKF) is focused on transforming healthcare with their evidence-based digital health software solutions, aiming to deliver the latest clinical information and data to empower clinicians. The Company is a trusted health system partner to a global client base that spans five continents across more than 13,000 healthcare facilities, rapidly growing through organic growth and a highly acquisitive strategy.
Beedie is the private equity arm managing the alternative investments and assets for Beedie Development Group (Real Estate Development). Beedie provides flexible financing solutions to companies seeking growth capital for acquisitions, new product launches, sales and marketing efforts and other strategic initiatives.
Origin Senior Leads: Cathy Steiner, Jim Meloche
Origin Merchant Partners is pleased to announce that Trafalgar Addiction Treatment Centre Inc. (“Trafalgar”) has been acquired by Canadian Addiction Treatment Centres (“CATC”). Origin Merchant Partners acted as exclusive financial advisor to Trafalgar with respect to this transaction.
Trafalgar is an industry-leading addiction treatment provider founded in 2013 to provide Cognitive Behavioural Therapy based protocols to address addictions and concurrent mental health disorders. Trafalgar’s programs, both inpatient and virtual, are accredited by the Commission on Accreditation of Rehabilitation Facilities with the virtual outpatient programming being the first of its kind to receive such accreditation.
CATC was founded in 1995 with the mission to expand access to evidence-based addiction treatment for people suffering from opioid use disorder. CATC offers a comprehensive care model designed to meet the broader health needs of patients including Methadone and Suboxone assisted therapy, harm reduction services, basic primary care, and inpatient treatment such as at their GreeneStone residence.
Senior Leads: Charles Pennock, Cathy Steiner
Origin Merchant Partners is pleased to announce that CareRx Corporation (“CareRx”) has closed its previously announced acquisition of the Long-Term Care Pharmacy Division of Medical Pharmacies Group Limited (“MPGL”). Origin Merchant Partners acted as the financial advisor to CareRx on this transaction.
CareRx (TSX:CRRX) is one of Canada’s leading and most trusted providers of comprehensive Specialty Pharmacy services and solutions to seniors, operating a large national network of pharmacy fulfilment centres that deliver high-volume solutions for the cost-effective supply of chronic medication and other specialty clinical pharmacy services. With services that address the growing demand within the Canadian healthcare system, CareRx’s unparalleled national care delivery platform provides significant potential for future expansion and growth.
MPGL is one of Canada’s leading continuing care pharmacies, providing services and support to complex continuing care residents and clients across Ontario, Alberta and British Columbia. MPGL also provides specialty pharmacy services and support to physician and specialist clinics, hospitals and other care institutions.
Origin Senior Leads: Tedi Gjoleka, Jim Osler, Jim Meloche, Cathy Steiner
Origin Merchant Partners is pleased to announce that CareRx Corporation (“CareRx”) has acquired Rexall Pharmacy Group’s long-term care pharmacy business in Ontario and Northern Alberta. CareRx adds approximately 4,000 senior care residents to its network through this acquisition, for a total of approximately 56,000 residents in over 950 seniors and other congregate care communities. Origin Merchant Partners acted as the financial advisor to CareRx on this transaction.
CareRx (TSX:CRRX) is one of Canada’s leading and most trusted providers of comprehensive Specialty Pharmacy services and solutions to seniors, operating a large national network of pharmacy fulfilment centres that deliver high-volume solutions for the cost-effective supply of chronic medication and other specialty clinical pharmacy services. With services that address the growing demand within the Canadian healthcare system, CareRx’s unparalleled national care delivery platform provides significant potential for future expansion and growth.
Rexall Pharmacy Group is a chain of retail pharmacies in Canada that operates Rexall and Rexall Pharma Plus in Central and Western Canada. Rexall is owned by McKesson Canada Corporation, which is a subsidiary of McKesson Corporation, a U.S.-based public company.
Origin Senior Leads: Tedi Gjoleka, Jim Osler, Jim Meloche, Cathy Steiner
Origin Merchant Partners is pleased to announce that Dapasoft Inc. (“Dapasoft”) , including Dapasoft and its wholly owned subsidiary, iSecurity, has been acquired by Calian Group Ltd (“Calian”). Origin Merchant Partners acted as exclusive financial advisor to Dapasoft with respect to this transaction.
Dapasoft is trusted by North American healthcare providers, payors, and application developers to power their solutions, integrating a wide variety of EHR, EMR, and other clinical and analytics systems. Dapasoft’s wholly owned subsidiary, iSecurity delivers world-class enterprise solutions that manage cybersecurity risk while addressing unique regulatory requirements and critical infrastructure.
Calian (TSX: CGY) Calian employs over 4,400 people in its delivery of diverse products and solutions for private sector, government and defence customers in North American and global markets. The Company’s diverse capabilities are delivered through: Advanced Technologies, Health, Learning, and IT and Cyber Solutions.
Origin Senior Leads: Cathy Steiner, Lindsay Adam Weiss, Shaun Quennell
Origin Merchant Partners is pleased to announce that LifeSpeak Inc. (“Lifespeak”) has raised $42 million in an equity investment from a syndicate including Round13 Growth Fund, Roynat Capital, and Kensington Capital Partners. Origin Merchant Partners was the exclusive financial advisor to LifeSpeak with respect to this transaction.
LifeSpeak is a leading digital mental health and wellness education platform, providing employees, health plan members and their families with remote access to leading experts in mental health, physical wellness, financial health, family relationships and professional skills development, through a proprietary collection of content and tools. A North American leader in well-tech, LifeSpeak has a well-established 16 year track record of effectiveness, engagement and client retention.
Round13 Growth Fund (“Round13”) invests in Canadian based growth opportunities including those in technology and healthcare, as well as more traditional industries where there is an opportunity for technology enablement. Round13 helps to bridge the late-stage growth funding gap in Canada between traditional venture capital and public market investors.
Roynat Inc.(“Roynat”) is a wholly owned subsidiary of Scotiabank, one of North America’s premier financial institutions and Canada’s international bank. Roynat provides alternative financing solutions to Canadian mid-market businesses.
Kensington Capital Partners (“Kensington”) is a leading Canadian alternative investment firm with $ 1.5 billion in assets under management. Kensington’s portfolio of innovative investments includes diversified funds focused on private equity, venture capital, infrastructure assets and hedge funds.
Origin Senior Leads: Mario Di Pietro, Cathy Steiner, Christopher Solda
Origin Merchant Partners is pleased to announce that Village Farms International, Inc. (“Village Farms”) has announced it has entered into a definitive purchase and sale agreement with Emerald Health Therapeutics, Inc. (“Emerald”) to acquire the remaining common shares of Pure Sunfarms Corp. (“Pure Sunfarms”) from Emerald for $79.9 million. Upon completion of the transaction, Village Farms will own 100% of the common shares of Pure Sunfarms. Origin Merchant Partners acted as the exclusive financial advisor to Village Farms on this transaction.
Village Farms (TSX:VFF, NASDAQ: VFF) is one of the largest and longest-operating greenhouse growers in North America, and is leveraging its decades of experience as a large-scale, low-cost intensive agriculture and vertically integrated produce supplier to pursue high-value, high-growth plant-based Consumer Packaged Goods opportunities in cannabis and CBD in North America and selected markets internationally.
Pure Sunfarms is one of the single largest cannabis operations in the world, the lowest-cost greenhouse producer, one of the best-selling brands, and has generated profitability for six consecutive quarters.
Origin Senior Leads: Jim Osler, Jim Meloche
Origin Merchant Partners is pleased to announce that Centric Health Corp. (“Centric”) has successfully completed the acquisition of Remedy Holdings Inc. and Remedy’sRx Specialty Pharmacy Business (“Remedy”). Origin Merchant Partners acted as the financial advisor to Centric on this transaction.
Centric Health (TSX:CHH) is one of Canada’s leading and most trusted providers of comprehensive Specialty Pharmacy services and solutions to seniors. Centric Health operates a large national network of pharmacy fulfilment centres that deliver high-volume solutions for the cost-effective supply of chronic medication and other specialty clinical pharmacy services. Following the acquisition Centric will serve more than 50,000 residents in over 800 seniors’ communities (long-term care, retirement homes, and assisted living facilities) nationally. With services that address the growing demand within the Canadian healthcare system, Centric Health’s unparalleled national care delivery platform provides significant potential for future expansion and growth.
Remedy Holdings Inc. provides medication management services to approximately 19,300 residents in over 400 long term care, assisted living, independent living, retirement, and group homes. Remedy’sRx Specialty Pharmacy operates 13 pharmacies across Ontario, Alberta and British Columbia.
Origin Senior Leads: Jim Meloche, Jim Osler, Cathy Steiner, Tedi Gjoleka
Origin Merchant Partners is pleased to announce Centric Health Corp. (“Centric”) has completed a term loan financing of up to $30 million by Crown Capital Partners Inc. (“Crown”), an investment fund managed by Crown and in which Crown holds an approximate 39% interest.
Origin Merchant Partners and Origin Merchant Securities Inc. acted as the financial advisor to Centric in both of these transactions respectively.
Centric Health (TSX:CHH) is one of Canada’s leading, and most trusted providers of comprehensive Specialty Pharmacy services and solutions to seniors. Centric operates a large national network of pharmacy fulfilment centres that deliver high-volume solutions for the cost-effective supply of chronic medication and other specialty clinical pharmacy services, serving more than 31,000 residents in over 460 seniors communities (long-term care, retirement homes, and assisted living facilities) nationally. With services that address the growing demand within the Canadian healthcare system, Centric’s unparalleled national care delivery platform provides significant potential for future expansion and growth.
Crown Capital Partners Inc. (TSX:CRWN) is a specialty finance company focused on providing capital to middle-market companies that are seeking alternatives to banks and private equity funds. Crown provides customized solutions in the form of loans, royalties, and other structures with minimal or no ownership dilution. In addition to deploying capital as a principal investor, Crown develops, manages and co- invests in alternative investment funds, including Crown Partners Fund and Crown Capital Power Fund.
Origin Senior Leads: Jim Meloche, Jim Osler, Cathy Steiner, Tedi Gjoleka
Origin Merchant Partners is pleased to announce that Centric Health Corp. (“Centric”) has successfully completed two transactions to recapitalize the balance sheet with $70M of gross proceeds. Centric closed the sale of its Surgical and Medical Centres business to the Kensington Private Equity Fund for $35 million. Centric also closed a private placement of common shares and convertible debentures. The lead investor was Yorkville Asset Management Inc. behalf of certain managed funds.
Origin Merchant Partners and Origin Merchant Securities Inc. acted as the financial advisor to Centric in both of these transactions respectively.
Centric Health (TSX:CHH) is one of Canada’s leading, and most trusted providers of comprehensive Specialty Pharmacy services and solutions to seniors. Centric operates a large national network of pharmacy fulfilment centres that deliver high-volume solutions for the cost-effective supply of chronic medication and other specialty clinical pharmacy services, serving more than 31,000 residents in over 450 seniors communities (long-term care, retirement homes, and assisted living facilities) nationally. With services that address the growing demand within the Canadian healthcare system, Centric’s unparalleled national care delivery platform provides significant potential for future expansion and growth.
Kensington Capital Advisors Inc. is a leading independent Canadian investor in alternative assets. Founded in 1996, and with over $1.5 billion invested in private equity, venture capital, and alternative assets. Kensington’s active management approach and relationship-based business has generated top quartile returns for investors.
Yorkville Asset Management is an independent investment boutique with a strong focus on the healthcare sector in Canada. Yorkville aims to help high net worth individuals, foundations, institutions, and family offices achieve their financial goals through its wealth management, estate and tax planning, portfolio management, and capital markets debt and equity advisory services.
Origin Senior Leads: Jim Meloche, Cathy Steiner, Tedi Gjoleka
Origin Merchant Partners is pleased to announce that Centric Health Corp. (“Centric”) has successfully completed two transactions to recapitalize the balance sheet with $70M of gross proceeds. Centric closed the sale of its Surgical and Medical Centres business to the Kensington Private Equity Fund for $35 million. Centric also closed a private placement of common shares and convertible debentures. The lead investor was Yorkville Asset Management Inc. behalf of certain managed funds.
Origin Merchant Partners and Origin Merchant Securities Inc. acted as the financial advisor to Centric in both of these transactions respectively.
Centric Health (TSX:CHH) is one of Canada’s leading, and most trusted providers of comprehensive Specialty Pharmacy services and solutions to seniors. Centric operates a large national network of pharmacy fulfilment centres that deliver high-volume solutions for the cost-effective supply of chronic medication and other specialty clinical pharmacy services, serving more than 31,000 residents in over 450 seniors communities (long-term care, retirement homes, and assisted living facilities) nationally. With services that address the growing demand within the Canadian healthcare system, Centric’s unparalleled national care delivery platform provides significant potential for future expansion and growth.
Kensington Capital Advisors Inc. is a leading independent Canadian investor in alternative assets. Founded in 1996, and with over $1.5 billion invested in private equity, venture capital, and alternative assets. Kensington’s active management approach and relationship-based business has generated top quartile returns for investors.
Yorkville Asset Management is an independent investment boutique with a strong focus on the healthcare sector in Canada. Yorkville aims to help high net worth individuals, foundations, institutions, and family offices achieve their financial goals through its wealth management, estate and tax planning, portfolio management, and capital markets debt and equity advisory services.
Origin Senior Leads: Jim Meloche, Cathy Steiner, Tedi Gjoleka
Origin Merchant Securities Inc. is pleased to announce that Pivot Pharmaceuticals Inc. has successfully completed a $5 million private placement of convertible debentures.
Origin Merchant Securities Inc. acted as exclusive financial advisor to Pivot with respect to this transaction.
Pivot Pharmaceuticals Inc. (“Pivot”) is a vertically-integrated cannabis company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s proprietary topical and oral drug delivery technologies improve the bioavailability of cannabinoid, cannabidiol (CBD), and tetrahydrocannabinol (THC)-based products. Pivot’s initial product development candidates will include topical treatments for women’s sexual dysfunction, as well as psoriasis, and an oral product for cancer supportive care.
Origin Senior Lead: Cathy Steiner
Origin Merchant Partners was retained by the Board and Executive Committee of Aeterna Zentaris (“Aeterna” or the “Company”) to provide a fairness opinion with respect to the Company’s license and assignment agreement with Strongbridge Biopharma LLC, regarding its primary drug, Macrilen, the first FDA-approved oral drug indicated for the diagnosis of Adult Growth Hormone Deficiency.
Aeterna Zentaris Inc. is a specialty biopharmaceutical company focused on developing and commercializing new treatments, principally through out-licensing arrangements.
Strongbridge Biopharma LLC. is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs.
Origin Senior Leads: Cathy Steiner, Jim Osler
Origin Merchant Partners is pleased to announce the successful sale of Addition Technology, Inc. (“Addition Technology”) to AJL Ophthalmic, S.A. (“AJL Ophthalmic”). Origin Merchant Partners acted as exclusive financial advisor to Addition with respect to the transaction.
Addition Technology is a certified ophthalmic device company, developing corneal implants for patients with moderate nearsightedness. Addition Technology offers the only FDA approved intracorneal segments for the treatment of Myopia and Keratoconus. Based in Sunnyvale, California, the company serves customers within the United States and internationally.
AJL Ophthalmic specializes in manufacturing medical products ranging from ophthalmology, airflow and craniofacial reconstruction to veterinary equipment and accessories. AJL Ophthalmic is located in Alava, Spain.
